Raman Venkataramanan
Professor · University of Pittsburgh School of Pharmacy · University of Pittsburgh
Quick answer: Raman Venkataramanan is Professor at University of Pittsburgh. Raman Venkataramanan shows an active PhD hiring signal as of 2026-09-11.
⭐ Accepting MS Students
Accepting PhD Students
Research interests
Venkat’s research focuses on optimizing drug therapy in pregnancy “prevention of preterm labor by optimizing the use of 17-hydroxyprogesterone caproate during pregnancy and Optimizing buprenorphine treatment in pregnancy”; and “optimization of use of medications in organ transplant patients”. Consistently NIH funded for OBGYN pharmacology work for the past 20years.
Biosketch:
Raman Venkataramanan, Ph.D; FCP; FAAPS
Distinguished Service Professor of Pharmaceutical sciences and Pathology, University of Pittsburgh.
Director of clinical pharmacokinetics laboratory
Director of Therapeutic Drug Monitoring and Toxicology, UPMC
Interim Director of CPPF, HCC, UPMC
Pharmacy degree from University of Madras, India
Master of pharmacy from Birla Institute of Technology and Science, India;
Doctorate from University of British Columbia, Canada.
Postdoctoral fellowship at the University of Washington
Faculty University of Pittsburgh since 1980.
Editorial board member for Therapeutic Drug Monitoring, and four online journals.
Editor for the American Journal of Analytical Chemistry.
Reviewer for 10 additional journals
Presented more than 200 lectures/seminars at national/international meetings
Published over 450 papers in peer reviewed journals
Mentored 39 Ph.Ds; 10 MS; 30 Fellows; 10 Faculty
Member in AAPS, ACCP, IATDMCT, ITS and AST.
Residency:
Solid Organ Transplant
Resident Position:
Preceptor
Drug Discovery and Development; Clinical Pharmaceutical Sciences; Drug Formulations and Delivery; Drug Abuse and Prevention; Pharmacogenetics
Selected publications (since 2023)
423. Yoshida S, Kreger AM, Shaik IH, West RE 3rd, Venkataramanan R, Gittes GK. Intra-amniotic sildenafil administration in rabbits: Safety, pharmacokinetics, organ distribution and histologic evaluation. Toxicol Appl Pharmacol. 2023 Jun 15;469:116527. doi: 10.1016/j.taap.2023.116527. Epub 2023 Apr 18. PMID: 37080362.
424. Firuz G. Feturi,1 Vasil E. Erbas,2 Zhaoxiang Zhang,3 Lewei Dong,3 Huseyin Sahin,4 Jonas T. Schnider,3 Yang Li,3 Sinan Oksuz,5 Wensheng Zhang,3 Sean Mcclaine,3 Jan Niec,3 Jan Plock,6 Jignesh V. Unadkat,3 Kia M. Washington,3,7 Alexander M. Spiess,3 Mario G. Solari,3 Vijay S. Gorantla,8 Raman Venkataramanan,1,9 Topical Immunotherapy Synergizes with Low Systemic Immunotherapy to Prolong Survival of Vascularized Composite Allografts without Systemic Adverse Effects (J Pharm Sc
Frequently asked questions
Is Raman Venkataramanan hiring PhD students at University of Pittsburgh?
Yes. As of 2026-09-11, Raman Venkataramanan's faculty page shows a PhD hiring signal: Accepting MS Students
Accepting PhD Students.
What does Raman Venkataramanan research?
Venkat’s research focuses on optimizing drug therapy in pregnancy “prevention of preterm labor by optimizing the use of 17-hydroxyprogesterone caproate during pregnancy and Optimizing buprenorphine treatment in pregnancy”; and “optimization of use of medications in organ transplant patients”. Consis
Data last updated: 2026-09-11 · Source: phd-match.com faculty database.
Is Raman Venkataramanan a match for your research?
Upload your CV and get matched to professors who fit — with hiring signals.
Start matching